Monday, January 10, 2011

PDL BioPharma loses in ND Ca

Bloomberg noted on 10 January 11:

The antibody Synagis is made by AstraZeneca's Plc's Medimmune unit. In the decision, the U.S. District Court for the Northern District of California said PDL's patent infringement claim was invalid and that Medimmune did not violate a license agreement on royalties.


Post a Comment

<< Home